Arati Desai, MD, MAS

faculty photo
Associate Professor of Clinical Medicine (Hematology-Oncology)
Attending, Inpatient Oncology Service, Hospital of the University of Pennsylvania
Director of the Penn Brain Tumor Center (PBTC) , University of Pennsylvania
Institutional Principal Investigator for the Adult Brain Tumor Consortium (ABTC), University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-307
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-349-8140
Fax: 215-662-7804
Education:
A.B. (English, Certificate in Women's Studies)
Princeton University, 1996.
M.D. (Medicine)
University of Kentucky College of Medicine, 2001.
M.A.S. (Advanced Studies in Clinical Research)
University of California, San Francisco, 2006.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Mohan S, Wang S, Chawla S, Abdullah K, Desai A, Maloney E, Brem S.: Multiparametric MRI assessment of response to convection-enhanced intratumoral delivery of MDNA55, an interleukin-4 receptor targeted immunotherapy, for recurrent glioblastoma. Surg Neurol Int 12: 337, Jul 2021.

Akbari H, Kazerooni AF, Ware JB, Mamourian E, Anderson H, Guiry S, Sako C, Raymond C, Yao J, Brem S, O'Rourke DM, Desai AS, Bagley SJ, Ellingson BM, Davatzikos C, Nabavizadeh A.: Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging. Sci Rep 11: 15011, Jul 2021.

Durgin JS, Henderson F Jr, Nasrallah MP, Mohan S, Wang S, Lacey SF, Melenhorst JJ, Desai AS, Lee JYK, Maus MV, June CH, Brem S, O'Connor RS, Binder Z, O'Rourke DM.: Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma. Front Oncol 11: 669071, May 2021.

Bagley SJ, Till J, Abdalla A, Sangha HK, Yee SS, Freedman J, Black TA, Hussain J, Binder ZA, Brem S, Desai AS, O'Rourke DM, Long Q, Nabavizadeh SA, Carpenter EL.: Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma. Neurooncol Adv 3: vdab011, Jan 2021.

Stephen J Bagley, Arati S Desai, Gerald P Linette, Carl H June, Donald M O'Rourke. : CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges Neuro Oncol 20(11): 1429-1438. Oct 9 2020.

Mac Lean P Nasrallah, Arati Desai, Donald M O'Rourke, Lea F Surrey, Joel M Stein. : A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features Acta Neuropathol Commun 8(1): 115, Jul 20 2020.

Hamed Akbari, Saima Rathore, Spyridon Bakas, MacLean P Nasrallah, Gaurav Shukla, Elizabeth Mamourian, Martin Rozycki, Stephen J Bagley , Jeffrey D Rudie, Adam E Flanders, Adam P Dicker, Arati S Desai, Donald M O'Rourke, Steven Brem, Robert Lustig, Suyash Mohan, Ronald L Wolf, Michel Bilello, Maria Martinez-Lage, Christos Davatzikos. : Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma. Cancer 126(11): 2625-2636, Jun 1 2020.

Stephen J Bagley, Arati S Desai, MacLean P Nasralla, Donald M O'Rourke. : Immunotherapy and Response Assessment in Malignant Glioma: Neuro-oncology Perspective Review 29(2): 95-102, Apr 2020.

Fraser Henderson Jr, Steven Brem, Donald M O'Rourke, MacLean Nasrallah, Vivek P Buch, Anthony J Young, Robert K Doot, Austin Pantel, Arati Desai, Stephen J Bagley, S Ali Nabavizadeh. : 18 F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling Neurooncol Pract 7(2): 152-157, Mar 2020.

Sumei Wang, Donald M O'Rourke, Sanjeev Chawla, Gaurav Verma, MacLean P Nasrallah, Jennifer J D Morrissette, Gabriela Plesa, Carl H June, Steven Brem ,Eileen Maloney, Arati Desai, Ronald L Wolf, Harish Poptani, Suyash Mohan. : Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma Br J Cancer 120(1): 54-56, Jan 2020.

back to top
Last updated: 11/02/2022
The Trustees of the University of Pennsylvania